Cipla Ltd. announcements
In the twelve months since 23 September 2025 Cipla Ltd. made 129 announcements to NSE under Regulation 30: 22 general updates, 18 analysts/institutional investor meet/con. call updates, 14 copy of newspaper publication, 11 updates, 10 outcome of board meeting, 7 change in management. The latest, on 22 September 2026, was filed under change in management; the table carries the company's own summary of each and the PDF.
| Date | Category | What the company told the exchange | Filing |
|---|---|---|---|
| 22 September 2026 | Change in Management | Cipla Limited has informed the Exchange about change in Senior Management Personnel. | |
| 18 September 2026 | General Updates | Intimation under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | |
| 3 September 2026 | Press Release | Cipla Limited has informed the Exchange regarding a press release dated September 03, 2026, titled "Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US". | |
| 3 September 2026 | General Updates | Notice to shareholders and creditors in accordance with NCLT Order dated 18th August, 2026 regarding merger of Inzpera Healthsciences Limited with the Company. | |
| 2 September 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Newspaper Publication regarding opening of special window for re-lodgement of transfer and dematerialisation of physical shares | |
| 31 August 2026 | Press Release | Cipla Limited has informed the Exchange regarding a press release dated August 31, 2026, titled "Cipla and SBP Group sign exclusive licensing agreement for potential best-in-class HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102)". | |
| 28 August 2026 | General Updates | Cipla Limited has informed the Exchange about Update on USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA | |
| 27 August 2026 | Other Restructuring | Cipla Limited has informed the Exchange about Other Restructuring | |
| 27 August 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Schedule of meet | |
| 26 August 2026 | ESOP/ESOS/ESPS | Cipla Limited has informed the Exchange regarding Allotment of 5281 Shares. | |
| 25 August 2026 | General Updates | Cipla Limited has informed the Exchange about USFDA inspection at Company s manufacturing facility in Pithampur, India | |
| 19 August 2026 | Amalgamation/Merger | Cipla Limited has informed the Exchange about receipt of order from Hon'ble NCLT, Mumbai Bench. | |
| 11 August 2026 | General Updates | Cipla Limited has informed the Exchange about ESG Ratings. | |
| 4 August 2026 | General Updates | Update on USFDA inspection at InvaGen manufacturing facility in Hauppauge, Long Island, New York, USA | |
| 31 July 2026 | Allotment of Securities | Cipla Limited has informed the Exchange regarding allotment of 7850 securities pursuant to ESOP/ESPS at its meeting held on July 31, 2026 | |
| 27 July 2026 | Updates | Cipla Limited has informed the Exchange regarding 'Cipla Receives U.S. FDA Approval for Generic Advair Diskus®'. | |
| 27 July 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Transcript | |
| 24 July 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Copy of Newspaper Publication of the unaudited financial results for the quarter ended 30th June, 2026. | |
| 23 July 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Link of Recording | |
| 23 July 2026 | Updates | Cipla Limited has informed the Exchange that the Board has approved the changes in the Key Managerial Personnels (KMPs) and Officers authorised under Regulation 30(5) of the SEBI Listing Regulations. | |
| 23 July 2026 | Updates | Cipla Limited has informed the Exchange regarding 'Grant Of Stock Options and Employee Stock Appreciation Rights'. | |
| 23 July 2026 | Change in Management | Cipla Limited has informed the Exchange about change in management. | |
| 23 July 2026 | Outcome of Board Meeting | Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on July 23, 2026. | |
| 23 July 2026 | Press Release | Cipla Limited has informed the Exchange regarding a press release dated July 23, 2026, titled 'Q1 FY27 Results' | |
| 23 July 2026 | Investor Presentation | Cipla Limited has informed the Exchange about Investor Presentation | |
| 23 July 2026 | Outcome of Board Meeting | Cipla Limited has submitted to the Exchange, the financial results for the period ended June 30, 2026. | |
| 18 July 2026 | General Updates | Cipla Limited has informed the Exchange about USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA | |
| 13 July 2026 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Cipla Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 12 July 2026 | General Updates | Cipla Limited has informed the Exchange about ESG Rating. | |
| 8 July 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Schedule of meet | |
| 4 July 2026 | Updates | Cipla Limited has informed the Exchange regarding corrigendum to the intimation dated 3rd July, 2026 regarding 'Transcript of the 90th Annual General Meeting' | |
| 3 July 2026 | Updates | Cipla Limited has informed the Exchange regarding 'Transcript of the 90th Annual General Meeting '. | |
| 2 July 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Newspaper Publication regarding opening of special window for lodgement of transfer and dematerialisation of physical shares | |
| 25 June 2026 | Change in Auditors | Cipla Limited has informed the Exchange regarding Change in Auditors of the company. | |
| 25 June 2026 | Shareholders meeting | Cipla Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 25, 2026 | |
| 25 June 2026 | Shareholders meeting | Cipla Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 25, 2026. Further, the company has informed the Exchange regarding voting results. | |
| 25 June 2026 | General Updates | Cipla Limited has informed the Exchange about ESG Rating. | |
| 19 June 2026 | Disclosure under SEBI Takeover Regulations | Dr. Y. K. Hamied has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | |
| 18 June 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Newspaper advertisement titled Notice to shareholders for transfer of shares to the Investor Education and Protection Fund | |
| 16 June 2026 | Updates | Cipla Limited has informed the Exchange regarding 'Grant Of Stock Options and Employee Stock Appreciation Rights'. | |
| 16 June 2026 | Change in Management | Cipla Limited has informed the Exchange about change in Management | |
| 11 June 2026 | General Updates | Cipla Limited has informed the Exchange about USFDA inspection at Company s manufacturing facility in Verna, Goa, India | |
| 9 June 2026 | General Updates | Cipla Limited has informed the Exchange about corrigendum to the intimation dated 1st June, 2026 regarding Notice of the 90th Annual General Meeting ( AGM ) along with Integrated Annual Report for FY 2025-26 | |
| 8 June 2026 | General Updates | Cipla Limited has informed the Exchange about communication on tax deduction at source on final dividend for FY 2025-26. | |
| 4 June 2026 | ESOP/ESOS/ESPS | Cipla Limited has informed the Exchange regarding Allotment of 44770 Shares. | |
| 2 June 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about newspaper advertisement titled 'Notice of the 90th Annual General Meeting and E-voting Information | |
| 2 June 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Schedule of meet | |
| 1 June 2026 | Updates | Cipla Limited has informed the Exchange regarding BRSR for FY2025-26 | |
| 1 June 2026 | Shareholders meeting | Cipla Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on Jun 25, 2026 | |
| 28 May 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Schedule of meet | |
| 21 May 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Newspaper advertisement titled "Notice of the 90th AGM to be held through Video Conferencing, Record Date and Final Dividend" | |
| 15 May 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Transcript | |
| 14 May 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Copy of Newspaper Publication | |
| 14 May 2026 | Allotment of Securities | Cipla Limited has informed the Exchange regarding allotment of 17915 securities pursuant to ESOP/ESPS on May 14, 2026 | |
| 13 May 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Link of Recording | |
| 13 May 2026 | Updates | Cipla Limited has informed the Exchange regarding grant of stock options and the employee stock appreciation rights . | |
| 13 May 2026 | Appointment | Cipla Limited has informed the Exchange regarding Appointment of Ms Joshi Apte & Associates as Cost Auditors of the company w.e.f. April 01, 2026. | |
| 13 May 2026 | Appointment | Cipla Limited has informed the Exchange regarding Appointment of Mr Sushrut Kulkarni as President & Global Chief Integrated Product Development of the company w.e.f. May 18, 2026. | |
| 13 May 2026 | Outcome of Board Meeting | Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2026. | |
| 13 May 2026 | Investor Presentation | Cipla Limited has informed the Exchange about Investor Presentation | |
| 13 May 2026 | Press Release | Cipla Limited has informed the Exchange regarding a press release dated May 13, 2026. | |
| 13 May 2026 | Record Date | Cipla Limited has informed the Exchange that Record date for the purpose of Dividend is 05-Jun-2026. | |
| 13 May 2026 | Dividend | Cipla Limited has informed the Exchange that Board of Directors at its meeting held on May 13, 2026, recommended Final Dividend of Rs. 13 per equity share. | |
| 13 May 2026 | Outcome of Board Meeting | Cipla Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | |
| 6 May 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Newspaper Publications under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | |
| 23 April 2026 | General Updates | Cipla receives U.S. FDA approval for first AB Rated Generic of Ventolin® HFA | |
| 17 April 2026 | General Updates | Cipla Limited has informed the Exchange about USFDA inspection at Company's manufacturing facility in Goa, India | |
| 16 April 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Schedule of Earnings Conference call | |
| 16 April 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about newspaper publication regarding Second 100-day Campaign 'Saksham Niveshak' | |
| 9 April 2026 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Cipla Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 30 March 2026 | Resignation | Cipla Limited has informed the Exchange regarding Resignation of Mr. Umang Vohra as Managing Director & CEO of the company w.e.f. April 01, 2026. | |
| 30 March 2026 | Change in Management | Cipla Limited has informed the Exchange about change in Management | |
| 28 March 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Newspaper Publication regarding opening of special window for lodgement of transfer and dematerialisation of physical shares | |
| 26 March 2026 | Shareholders meeting | Cipla Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. | |
| 26 March 2026 | Updates | Mr Pradeep Bhadauria, Global Chief Scientific Officer has resigned to pursue interests outside Cipla and his last working day will be 31st March, 2026. | |
| 19 March 2026 | Outcome of Board Meeting | Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on March 19, 2026 regarding:1. Approved investment upto USD 100 million in the equity share capital of Cipla (EU) Limited, a whollyowned subsidiary of the Company for the purpose of providing onward financial assistance to InvaGen Pharmaceuticals Inc., wholly-owned subsidiary of Cipla (EU) Limited, to meet its capital ... | |
| 19 March 2026 | Outcome of Board Meeting | Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on March 19, 2026. | |
| 18 March 2026 | Allotment of Securities | Cipla Limited has informed the Exchange regarding allotment of 1954 securities pursuant to ESOP/ESPS at its meeting held on March 18, 2026 | |
| 9 March 2026 | General Updates | Cipla Limited has informed the Exchange about General Updates | |
| 2 March 2026 | Acquisition | Cipla Limited has informed the Exchange about entering into a venture agreement with Kemwell Biopharma Private Limited ( Kemwell ) for incorporation of a joint venture company in India. | |
| 2 March 2026 | Incorporation | Cipla Limited has informed the Exchange about incorporation of a wholly-owned step-down subsidiary named Cipla Middle East Company w.e.f. 1st March, 2026, in the Kingdom of Saudi Arabia. | |
| 26 February 2026 | General Updates | Cipla Limited has informed the Exchange about ESG Rating. | |
| 24 February 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Copy of Newspaper Publication | |
| 23 February 2026 | Shareholders meeting | Cipla Limited has informed the Exchange regarding Notice of Postal Ballot | |
| 21 February 2026 | Updates | Cipla Limited has informed the Exchange regarding 'Update on US Food and Drug Administration (USFDA) inspection on Pharmathen International S.A. '. | |
| 17 February 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Schedule of meet | |
| 10 February 2026 | General Updates | Cipla Limited has informed the Exchange about General Updates | |
| 8 February 2026 | General Updates | Cipla Limited has informed the Exchange about General Updates | |
| 5 February 2026 | General Updates | Cipla Limited has informed the Exchange about General Updates | |
| 4 February 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Schedule of meet | |
| 2 February 2026 | Change in Management | Cipla Limited has informed the Exchange about change in Management | |
| 28 January 2026 | Allotment of Securities | Cipla Limited has informed the Exchange regarding allotment of 8879 securities pursuant to ESOP/ESPS at its meeting held on January 28, 2026 | |
| 27 January 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Transcript | |
| 24 January 2026 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Copy of Newspaper Publication | |
| 23 January 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Link of Recording | |
| 23 January 2026 | Updates | Cipla Limited has informed the Exchange that the Board has approved the changes in the Key Managerial Personnels (KMPs) and Officers authorised under Regulation 30(5) of the SEBI Listing Regulations with effect from 1st April 2026. | |
| 23 January 2026 | Change in Director(s) | Cipla Limited has informed the Exchange regarding Change in Director(s) of the company. | |
| 23 January 2026 | Outcome of Board Meeting | Cipla Limited has informed the Exchange that the Board has approved the re-appointment of Mr P R Ramesh as Independent Director of the Company for a second term of five consecutive years, subject to approval of the shareholders. | |
| 23 January 2026 | Investor Presentation | Cipla Limited has informed the Exchange about Investor Presentation | |
| 23 January 2026 | Press Release | Cipla Limited has informed the Exchange regarding a press release dated January 23, 2026, titled "Q3 FY26 Results". | |
| 23 January 2026 | Outcome of Board Meeting | Cipla Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | |
| 16 January 2026 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Cipla Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 14 January 2026 | General Updates | Cipla Limited has informed the Exchange about General Updates | |
| 9 January 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Schedule of meet | |
| 7 January 2026 | News Verification | The Exchange has sought clarification from Cipla Limited with respect to recent news item captioned Cipla shares fall 4% as partner gets US FDA observations. The response from the Company is attached. | |
| 7 January 2026 | News Verification | The Exchange has sought clarification from Cipla Limited with respect to recent news item captioned Cipla shares fall 4% as partner gets US FDA observations. The response from the Company is awaited. | |
| 30 December 2025 | Change in Management | Cipla Limited has informed the Exchange about change in Management | |
| 22 December 2025 | General Updates | Cipla Limited has informed the Exchange about General Updates | |
| 19 December 2025 | Arrangements for strategic, technical, manufacturing, or marketing tie up | Cipla Limited has informed the exchange that it has entered into an exclusive Supply and Marketing Agreement for Pfizer s brands | |
| 17 December 2025 | ESOP/ESOS/ESPS | Cipla Limited has informed the Exchange regarding Allotment of 585 Shares. | |
| 10 December 2025 | Product launch | Update on launch of Yurpeak® (Tirzepatide) in India for the treatment of Obesity and Type 2 Diabetes | |
| 10 December 2025 | General Updates | Cipla Limited has informed the Exchange about General Updates | |
| 4 December 2025 | Acquisition | Cipla Limited has informed the Exchange about Acquisition | |
| 6 November 2025 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Copy of Newspaper Publication | |
| 3 November 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Transcript | |
| 3 November 2025 | Acquisition | Cipla Limited has informed the Exchange about Acquisition | |
| 31 October 2025 | Copy of Newspaper Publication | Cipla Limited has informed the Exchange about Copy of Newspaper Publication | |
| 30 October 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Link of Recording | |
| 30 October 2025 | Press Release | Cipla Limited has informed the Exchange regarding a press release dated October 30, 2025, titled "Q2 FY26 Results". | |
| 30 October 2025 | Change in Director(s) | Cipla Limited has informed the Exchange regarding Change in Director(s) of the company. | |
| 30 October 2025 | Change in Management | Cipla Limited has informed the Exchange about change in Management | |
| 30 October 2025 | Outcome of Board Meeting | Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on October 30, 2025. | |
| 30 October 2025 | Investor Presentation | Cipla Limited has informed the Exchange about Investor Presentation | |
| 30 October 2025 | Outcome of Board Meeting | Cipla Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | |
| 29 October 2025 | ESOP/ESOS/ESPS | Cipla Limited has informed the Exchange regarding Allotment of 5518 Shares. | |
| 23 October 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Schedule of meet | |
| 23 October 2025 | Product launch | Cipla Limited has informed the Exchange about Product launch | |
| 19 October 2025 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Cipla Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | |
| 13 October 2025 | Analysts/Institutional Investor Meet/Con. Call Updates | Cipla Limited has informed the Exchange about Schedule of meet |
Regulation 30 of SEBI's listing regulations requires a company to tell the exchange of material events; the category is the exchange's, the words are the company's own summary as filed, cut to a few lines, and the PDF is the full filing.
Source
Corporate announcements on nseindia.com for CIPLA.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.